HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arteriovenous Fistula

An abnormal direct communication between an artery and a vein without passing through the CAPILLARIES. An A-V fistula usually leads to the formation of a dilated sac-like connection, arteriovenous aneurysm. The locations and size of the shunts determine the degree of effects on the cardiovascular functions such as BLOOD PRESSURE and HEART RATE.
Also Known As:
Arteriovenous Fistulas; Fistula, Arteriovenous; Fistulas, Arteriovenous; Aneurysm, Arteriovenous; Arteriovenous Aneurysm
Networked: 5003 relevant articles (172 outcomes, 390 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pathologic Constriction (Stenosis)
2. False Aneurysm (Pseudoaneurysm)
3. Fistula
4. Chronic Kidney Failure (Chronic Renal Failure)
5. Pain (Aches)

Experts

1. Roy-Chaudhury, Prabir: 40 articles (12/2021 - 03/2007)
2. Allon, Michael: 34 articles (07/2022 - 10/2002)
3. Lee, Timmy: 29 articles (07/2022 - 09/2009)
4. Jennings, William C: 27 articles (10/2022 - 12/2005)
5. Misra, Sanjay: 23 articles (12/2021 - 02/2008)
6. Shiu, Yan-Ting: 21 articles (01/2022 - 01/2014)
7. Asif, Arif: 18 articles (11/2020 - 06/2005)
8. Dardik, Alan: 17 articles (01/2022 - 08/2015)
9. Robbin, Michelle L: 17 articles (01/2022 - 10/2002)
10. Cheung, Alfred K: 16 articles (12/2021 - 01/2013)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Arteriovenous Fistula:
1. Paclitaxel (Taxol)FDA LinkGeneric
2. Indocyanine Green (Cardio-Green)FDA LinkGeneric
3. Anti-Bacterial Agents (Antibiotics)IBA
4. Polytetrafluoroethylene (Teflon)FDA Link
5. Prilocaine Drug Combination LidocaineFDA LinkGeneric
6. Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
7. Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
8. Fish OilsIBA
9. ThrombinFDA Link
10. Pancreatic Elastase (Elastase)IBA

Therapies and Procedures

1. Renal Dialysis (Hemodialysis)
2. Catheters
3. Stents
4. Therapeutics
01/01/1999 - "In general, outcome for the four classifications of AVMs are as follows: type I respond well to surgical disconnection of the arteriovenous fistula if treatment is early; type II AVMs are currently best treated by surgery but risks of a poor outcome need to be carefully considered; type III are only rarely treatable; type IVa and IVb are likely to respond well to surgery but our knowledge is limited; and type IVc are likely to fare poorly from surgery but should have a better outcome from endovascular therapy."
12/01/2013 - "Of 216 participants analyzed, including 97 with arteriovenous grafts (AVG) (49 FIR-radiated participants and 48 control participants) and 119 with arteriovenous fistulas (AVF) (69 FIR-radiated participants and 50 control participants), the FIR-radiated therapy compared with free-radiated usual therapy significantly enhanced PTA-unassisted patency at 1 year in the AVG subgroup (16.3% vs. 2.1%; p < .01), but not the AVF subgroup (25.0% vs. 18.4%; p = .50), and this accounted for the overall improved patency rates (21.4% vs. 10.3%; p = .02). "
10/01/2018 - "The objective of this study was to present a case of non-classic approach to the therapy of iatrogenic arteriovenous fistula. "
01/01/2017 - "The aim - to study short-term and long-term results of arteriovenous fistula exploitation as vascular access for continuous anticancer therapy. "
02/01/2013 - "This study aimed to investigate the treatment efficiency of interventional embolization therapy in puerile congenital deep femoral arteriovenous fistula. "
5. Central Venous Catheters